- Report
- November 2025
- 192 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 186 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 372 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 183 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 282 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 282 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 283 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 187 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 139 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 276 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 254 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 149 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 291 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 422 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 320 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 224 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 293 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 178 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 177 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 177 Pages
Global
From €5256EUR$5,850USD£4,637GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more